Blar i Institutt for nevromedisin og bevegelsesvitenskap på tidsskrift "Journal of Internal Medicine"
Viser treff 1-2 av 2
-
Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial
(Journal article; Peer reviewed, 2019)Background and objectives The 52‐week, randomized, double‐blind, noninferiority, government‐funded NOR‐SWITCH trial demonstrated that switching from infliximab originator to less expensive biosimilar CT‐P13 was not ... -
Vascular risk factor control and adherence to secondary preventive medication after ischemic stroke
(Peer reviewed; Journal article, 2020)Background Studies regarding adequacy of secondary stroke prevention are limited. We report medication adherence, risk factor control and factors influencing vascular risk profile following ischaemic stroke. Methods A ...